Trial Profile
A retrospective study evaluating the long-term benefits and safety of liraglutide in the management of diabetes mellitus in renal transplantation (RTx) recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2018
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 23 Oct 2018 New trial record
- 01 Oct 2018 Results published in the Transplantation Proceedings